Histo-blood group glycans in the context of personalized medicine

Biochimica et Biophysica Acta - General Subjects

Volumn 1860, Issue 8, 2016, Pages 1596-1607

  Dotz, Viktoria ^b   Wuhrer, Manfred ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Blood group; Cancer; Glycan; Infection; Personalized medicine; Vaccine

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; ALPHA 1,3 N ACETYLGALACTOSAMINYLTRANSFERASE; BETA 1,3 N ACETYLGALACTOSAMINYLTRANSFERASE 1; BETA 1,4 N ACETYLGALACTOSAMINYLTRANSFERASE 2; BLOOD GROUP ANTIGEN; EPITOPE; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 1; FUCOSYLTRANSFERASE 2; FUCOSYLTRANSFERASE 3; GALACTOSYLTRANSFERASE; GLOBOSIDE 3 ALPHA N ACETYL DEXTRO GALACTOSAMINYLTRANSFERASE; GLYCAN; GLYCOPROTEIN; LACTOSYLCERAMIDE 4 ALPHA GALACTOSYLTRANSFERASE; N ACETYLGALACTOSAMINYLTRANSFERASE; UNCLASSIFIED DRUG; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; OLIGOSACCHARIDE;

ANTIGEN EXPRESSION; ARTICLE; ASTHMA; BLOOD GROUP; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; BREAST CARCINOMA; CARBOHYDRATE ANALYSIS; CARDIOVASCULAR DISEASE; CHRONIC PANCREATITIS; CROHN DISEASE; ECHOVIRUS INFECTION; ESCHERICHIA COLI INFECTION; GENOTYPE; HELICOBACTER INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFLUENZA; INFLUENZA A; INFLUENZA B; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE METASTASIS; MALARIA; MENINGOCOCCOSIS; NECROTIZING ENTEROCOLITIS; NEOPLASM; NONHUMAN; NOROVIRUS INFECTION; PANCREAS CANCER; PATHOGENESIS; PEPTIC ULCER; PERSONALIZED MEDICINE; PHENOTYPE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RHINOVIRUS INFECTION; ROTAVIRUS INFECTION; SALMONELLOSIS; SCHISTOSOMIASIS MANSONI; SEPSIS; STOMACH CANCER; STOMACH DISEASE; STREPTOCOCCUS PNEUMONIA; URINARY TRACT INFECTION; CARDIOVASCULAR DISEASES; GENETICS; METABOLISM; NEOPLASMS; PROCEDURES;

ABO BLOOD-GROUP SYSTEM; CARDIOVASCULAR DISEASES; HUMANS; LEWIS BLOOD-GROUP SYSTEM; NEOPLASMS; OLIGOSACCHARIDES; PRECISION MEDICINE;

EID: 84954558209     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2015.12.026     Document Type: Article

References (161)

1. K. Landsteiner Ueber Agglutinationserscheinungen normalen menschlichen Blutes Wien. Klin. Wochenschr. 14 1901 1132 1134
2. J.R. Storry, L. Castilho, G. Daniels, W.A. Flegel, G. Garratty, M. de Haas, and et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012) Vox Sang. 107 2014 90 96 10.1111/vox.12127
3. ISBT (International Society of Blood Transfusion) Red cell immunogenetics and blood group terminology 2015 (2015) http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/ (accessed December 29, 2015)
4. V. Ravn, and E. Dabelsteen Tissue distribution of histo-blood group antigens APMIS 108 2000 1 28
5. U.E. Nydegger, H. Tevaearai, P. Berdat, R. Rieben, T. Carrel, P. Mohacsi, and et al. Histo-blood group antigens as allo- and autoantigens Ann. N. Y. Acad. Sci. 1050 2005 40 51 10.1196/annals.1313.006
6. W.M. Watkins Molecular basis of antigenic specificity in the ABO, H and Lewis blood-group systems J.V.M. J., H. Schachter, Glycoproteins 1995 Elsevier Science B.V Amsterdam 313 390
7. L.C. Martins, T.C. de Oliveira Corvelo, H.T. Oti, R.d.S.P. Loiola, D.C. Aguiar, K.A.d.S. Barile, and et al. ABH and Lewis antigen distributions in blood, saliva and gastric mucosa and H. pylori infection in gastric ulcer patients World J. Gastroenterol. 12 2006 1120 1124
8. A. Lundblad Excretion of oligosaccharides in the urine of secretors and non-secretors belonging to different blood groups Biochim. Biophys. Acta, Gen. Subj. 130 1966 130 142 10.1016/0304-4165(66)90015-8
9. R. Kuhn, and A. Gauhe Über ein kristallisiertes, Lea-aktives Hexasaccharid aus Frauenmilch Chem. Ber. 93 1960 647 651
10. A. Varki, and R.D. Cummings J.D. Esko, Glossary, Essentials Glycobiol 2009 http://www.ncbi.nlm.nih.gov/books/NBK1932/
11. D. Walt, K.F. Aoki-Kinoshita, C.R. Bertozzi, and G.-J. Boons Transforming Glycoscience: A Roadmap for the Future 2012 National Academies Press Washington (DC) http://www.ncbi.nlm.nih.gov/books/NBK109958/pdf/Bookshelf-NBK109958.pdf
12. L. Cooling Blood groups in infection and host susceptibility Clin. Microbiol. Rev. 28 2015 801 870 10.1128/CMR.00109-14
13. D.J. Anstee The relationship between blood groups and disease Blood 115 2010 4635 4643 10.1182/blood-2010-01-261859
14. K. Kato, and A. Ishiwa The role of carbohydrates in infection strategies of enteric pathogens Trop. Med. Health 43 2015 41 52 10.2149/tmh.2014-25
15. S.S. Pinho, and C.A. Reis Glycosylation in cancer: mechanisms and clinical implications Nat. Rev. Cancer 15 2015 540 555 10.1038/nrc3982
16. J. Heimburg-Molinaro, M. Lum, G. Vijay, M. Jain, A. Almogren, and K. Rittenhouse-Olson Cancer vaccines and carbohydrate epitopes Vaccine 29 2011 8802 8826 10.1016/j.vaccine.2011.09.009
17. M. Ducreux, A.S. Cuhna, C. Caramella, A. Hollebecque, P. Burtin, D. Goéré, and et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann. Oncol. 26 2015 v56 v68 10.1093/annonc/mdv295
18. P. Bugert, E.A. Scharberg, C. Geisen, I. von Zabern, and W.A. Flegel RhCE protein variants in Southwestern Germany detected by serologic routine testing Transfusion 49 2009 1793 1802 10.1111/j.1537-2995.2009.02220.x
19. F. Zhu, S. Tao, X. Xu, Y. Ying, X. Hong, H. Zhu, and et al. Distribution of ABO blood group allele and identification of three novel alleles in the Chinese Han population Vox Sang. 98 2010 554 559 10.1111/j.1423-0410.2009.01291.x
20. R.R. Race, and R. Sanger Blood Groups in Man sixth ed. 1975 Blackwell Scientific Publications Oxford
21. F.U. Weiss, C. Schurmann, A. Guenther, F. Ernst, A. Teumer, J. Mayerle, and et al. Fucosyltransferase 2 (FUT2) non-secretor status and blood group B are associated with elevated serum lipase activity in asymptomatic subjects, and an increased risk for chronic pancreatitis: a genetic association study Gut 64 2015 646 656 10.1136/gutjnl-2014-306930
22. D.P.B. McGovern, M.R. Jones, K.D. Taylor, K. Marciante, X. Yan, M. Dubinsky, and et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease Hum. Mol. Genet. 19 2010 3468 3476 10.1093/hmg/ddq248
23. L. Cooling Polylactosamines, there's more than meets the "Ii": a review of the I system Immunohematology 26 2010 133 155
24. R. Kaczmarek, A. Buczkowska, K. Mikołajewicz, H. Krotkiewski, and M. Czerwinski P1PK, GLOB, and FORS blood group systems and GLOB collection: biochemical and clinical aspects. Do We understand it all yet? Transfus. Med. Rev. 28 2014 126 136 10.1016/j.tmrv.2014.04.007
25. S.K. Patnaik, W. Helmberg, and O.O. Blumenfeld BGMUT: NCBI dbRBC database of allelic variations of genes encoding antigens of blood group systems Nucleic Acids Res. 40 2012 D1023 D1029 10.1093/nar/gkr958
26. F. Dall'Olio, N. Malagolini, M. Chiricolo, M. Trinchera, and A. Harduin-Lepers The expanding roles of the Sd(a)/Cad carbohydrate antigen and its cognate glycosyltransferase B4GALNT2 Biochim. Biophys. Acta 1840 2014 443 453 10.1016/j.bbagen.2013.09.036
27. L. Svensson, A.K. Hult, R. Stamps, J. Ångström, S. Teneberg, J.R. Storry, and et al. Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system J. Am. Soc. Hematol. 121 2013 1459 1468 10.1182/blood-2012-10-455055
28. G. Daniels Human blood Groups second ed. 2002 Wiley-Blackwell Hoboken
29. Z. Wilczynska, H. Miller-Podraza, and J. Koscielak The contribution of different glycoconjugates to the total ABH blood group activity of human erythrocytes FEBS Lett. 112 1980 277 279
30. S. Hakomori Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer Biochim. Biophys. Acta, Gen. Subj. 1473 1999 247 266 10.1016/S0304-4165(99)00183-X
31. H. Clausen, and S. Hakomori ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution Vox Sang. 56 1989 1 20
32. A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, et al., Structures Common to Different Glycans - Essentials of Glycobiology - NCBI Bookshelf, (n.d.). http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=glyco2&part=ch13#ch13.s7.
33. T. Feizi Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens Nature 314 1985 53 57
34. R. Oriol, J. Le Pendu, and R. Mollicone Genetics of ABO, H, Lewis, X and related antigens Vox Sang. 51 1986 161 171
35. R. Oriol Genetic control of the fucosylation of ABH precursor chains. Evidence for new epistatic interactions in different cells and tissues J Immunogenet. 17 1990 235 245
36. W.T. Morgan, and W.M. Watkins Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity Glycoconj. J. 17 2000 501 530
37. R. Mollicone, A. Cailleau, and R. Oriol Molecular genetics of H, Se, Lewis and other fucosyltransferase genes Transfus. Clin. Biol. 2 1995 235 242
38. L.C. Yu, and M. Lin Molecular genetics of the blood group I system and the regulation of I antigen expression during erythropoiesis and granulopoiesis Curr. Opin. Hematol. 18 2011 421 426 10.1097/MOH.0b013e32834baae9
39. F. Yamamoto, H. Clausen, T. White, J. Marken, and S. Hakomori Molecular genetic basis of the histo-blood group ABO system Nature 345 1990 229 233 10.1038/345229a0
40. A. Hellberg, J.S. Westman, B. Thuresson, and M.L. Olsson P1PK: the blood group system that changed its name and expanded Immunohematology 29 2013 25 33
41. W. Ebert, D. Roelcke, and H. Weicker The I Antigen of Human Red Cell Membrane Eur. J. Biochem. 53 1975 505 515 10.1111/j.1432-1033.1975.tb04093.x
42. J. Koscielak, E. Zdebska, Z. Wilczynska, H. Miller-Podraza, and W. Dzierzkowa-Borodej Immunochemistry of Ii-active glycosphingolipids of erythrocytes Eur. J. Biochem. 96 1979 331 337
43. E. Zdebska, R. Krauze, and J. Koscielak Structure and blood-group I activity of poly(glycosyl)-ceramides Carbohydr. Res. 120 1983 113 130
44. L.C. Yu, Y.C. Twu, C.Y. Chang, and M. Lin Molecular basis of the adult i phenotype and the gene responsible for the expression of the human blood group I antigen Blood 98 2001 3840 3845 10.1182/blood.V98.13.3840
45. O. Renkonen Enzymatic in vitro synthesis of I-branches of mammalian polylactosamines: generation of scaffolds for multiple selectin-binding saccharide determinants Cell. Mol. Life Sci. 57 2000 1423 1439
46. J. Le Pendu, R.U. Lemieux, A.M. Dalix, F. Lambert, and R. Oriol Competition between ABO and Le gene specified enzymes. I. A Lewis related difference in the amount of A antigen in saliva of A1 and A2 secretors Vox Sang. 45 1983 349 358
47. J. Le Pendu, R. Oriol, F. Lambert, A.M. Dalix, and R.U. Lemieux Competition between ABO and Le gene specified enzymes. II. Quantitative analysis of A and B antigens in saliva of ABH nonsecretors Vox Sang. 45 1983 421 425
48. W.M. Watkins, and W.T.J. Morgan Specific inhibition studies relating to the Lewis blood-group system Nature 180 1957 1038 1040 10.1038/1801038a0
49. P.H. Johnson, A.S. Donald, J. Feeney, and W.M. Watkins Reassessment of the acceptor specificity and general properties of the Lewis blood-group gene associated alpha-3/4-fucosyltransferase purified from human milk Glycoconj. J. 9 1992 251 264 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=1490104
50. J.P. Cartron, C. Mulet, B. Bauvois, C. Rahuel, and C. Salmon ABH and Lewis glycosyltransferases in human red cells, lymphocytes and platelets Rev. Fr. Transfus. 23 1980 271 282
51. S.M. Henry, R. Oriol, and B.E. Samuelsson Detection and characterization of Lewis antigens in plasma of Lewis-negative individuals. Evidence of chain extension as a result of reduced fucosyltransferase competition Vox Sang. 67 1994 387 396 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=7701811
52. T. Okuda, N. Tokuda, S. Numata, M. Ito, M. Ohta, K. Kawamura, and et al. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins J. Biol. Chem. 281 2006 10230 10235 10.1074/jbc.M600057200
53. A. Suchanowska, R. Kaczmarek, M. Duk, J. Lukasiewicz, D. Smolarek, E. Majorczyk, and et al. A Single Point Mutation in the Gene Encoding Gb3/CD77 Synthase Causes a Rare Inherited Polyagglutination Syndrome J. Biol. Chem. 287 2012 38220 38230 10.1074/jbc.M112.408286
54. T. Ju, V.I. Otto, and R.D. Cummings The Tn antigen-structural simplicity and biological complexity Angew. Chem. Int. Ed. Engl. 50 2011 1770 1791 10.1002/anie.201002313
55. B.K. Gillard, D. Blanchard, J.F. Bouhours, J.P. Cartron, J.A. van Kuik, J.P. Kamerling, and et al. Structure of a ganglioside with Cad blood group antigen activity Biochemistry 27 1988 4601 4606
56. F.J. Achermann, F. Julmy, L.G. Gilliver, T.P. Carrel, and U.E. Nydegger Soluble type A substance in fresh-frozen plasma as a function of ABO and secretor genotypes and Lewis phenotype Transfus. Apher. Sci. 32 2005 255 262 10.1016/j.transci.2004.05.007
57. M.L. Olsson, N.M. Irshaid, B. Hosseini-Maaf, A. Hellberg, M.K. Moulds, H. Sareneva, and et al. Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: identification of 15 novel A and B subgroup alleles Blood 98 2001 1585 1593
58. L. Hammar, S. Månsson, T. Rohr, M.A. Chester, V. Ginsburg, A. Lundblad, and et al. Lewis phenotype of erythrocytes and Le b-active glycolipid in serum of pregnant women Vox Sang. 40 1981 27 33 10.1111/j.1423-0410.1981.tb00665.x
59. W.L. Marsh Anti-i: a cold antibody defining the Ii relationship in human red cells Br. J. Haematol. 7 1961 200 209 http://www.ncbi.nlm.nih.gov/pubmed/13767181
60. A.J. Schaeffer, E.L. Navas, M.F. Venegas, B.E. Anderson, C. Kanerva, J.S. Chmiel, and et al. Variation of blood group antigen expression on vaginal cells and mucus in secretor and nonsecretor women J. Urol. 152 1994 859 864
61. P. Agrawal, T. Kurcon, K.T. Pilobello, J.F. Rakus, S. Koppolu, Z. Liu, and et al. Mapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode Proc. Natl. Acad. Sci. 111 2014 4338 4343 10.1073/pnas.1321524111
62. F. Yamamoto, E. Cid, M. Yamamoto, N. Saitou, J. Bertranpetit, and A. Blancher An integrative evolution theory of histo-blood group ABO and related genes Sci. Rep. 4 2014 6601 10.1038/srep06601
63. J. Koscielak The hypothesis on function of glycosphingolipids and ABO blood groups revisited Neurochem. Res. 37 2012 1170 1184 10.1007/s11064-012-0734-0
64. Y. Yu, Y. Lasanajak, X. Song, L. Hu, S. Ramani, M.L. Mickum, and et al. Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses Mol. Cell. Proteomics 13 2014 2944 2960 10.1074/mcp.M114.039875
65. D. Blank, V. Dotz, R. Geyer, and C. Kunz Human milk oligosaccharides and Lewis blood group: individual high-throughput sample profiling to enhance conclusions from functional studies Adv. Nutr. 3 2012 440S 449S 10.3945/an.111.001446
66. A.V. Everest-Dass, D. Jin, M. Thaysen-Andersen, H. Nevalainen, D. Kolarich, and N.H. Packer Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans Glycobiology 22 2012 1465 1479 10.1093/glycob/cws112
67. C.C. Blackwell, S. Dundas, V.S. James, D.A. Mackenzie, J.M. Braun, A.M. Alkout, and et al. Blood group and susceptibility to disease caused by Escherichia coli O157 J. Infect. Dis. 185 2002 393 396 10.1086/338343
68. G. Edgren, H. Hjalgrim, K. Rostgaard, R. Norda, A. Wikman, M. Melbye, and et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study Am. J. Epidemiol. 172 2010 1280 1285 10.1093/aje/kwq299
69. J. Ndamba, E. Gomo, N. Nyazema, N. Makaza, and K.C. Kaondera Schistosomiasis infection in relation to the ABO blood groups among school children in Zimbabwe Acta Trop. 65 1997 181 190 10.1016/S0001-706X(97)00671-2
70. B.L. Zhang, N. He, Y.B. Huang, F.J. Song, and K.X. Chen ABO blood groups and risk of cancer: a systematic review and meta-analysis Asian Pac. J. Cancer Prev. 15 2014 4643 4650
71. M.G. Robinson, D. Tolchin, and C. Halpern Enteric bacterial agents and the ABO blood groups Am. J. Hum. Genet. 23 1971 135 145
72. C. Timmann, T. Thye, M. Vens, J. Evans, J. May, C. Ehmen, and et al. Genome-wide association study indicates two novel resistance loci for severe malaria Nature 489 2012 443 446 10.1038/nature11334
73. S. Iodice, P. Maisonneuve, E. Botteri, M.T. Sandri, and A.B. Lowenfels ABO blood group and cancer Eur. J. Cancer 46 2010 3345 3350 10.1016/j.ejca.2010.08.009
74. M. Zhong, H. Zhang, J.P. Reilly, J.D. Chrisitie, M. Ishihara, T. Kumagai, and et al. ABO blood group as a model for platelet glycan modification in arterial thrombosis Arterioscler. Thromb. Vasc. Biol. 2015 10.1161/ATVBAHA.115.305337
75. J. Sheinfeld, A.J. Schaeffer, C. Cordon-Cardo, A. Rogatko, and W.R. Fair Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women N. Engl. J. Med. 320 1989 773 777 10.1056/nejm198903233201205
76. D.B. Teresa, R.A. Santos, C.S. Takahashi, H.H. Carrara, H.W. Moreira, L.C. Mattos, and et al. Polymorphisms of Lewis and secretor genes are related to breast cancer and metastasis in axillary lymph nodes Tumour Biol. 31 2010 401 409 10.1007/s13277-010-0048-2
77. Y.L. Chen, J.C. Chen, T.M. Lin, T.J. Huang, S.T. Wang, M.F. Lee, and et al. ABO/secretor genetic complex is associated with the susceptibility of childhood asthma in Taiwan Clin. Exp. Allergy 35 2005 926 932 10.1111/j.1365-2222.2005.02278.x
78. C.C. Blackwell, K. Jonsdottir, M. Hanson, W.T. Todd, A.K. Chaudhuri, B. Mathew, and et al. Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae Lancet 2 1986 284 285
79. C.C. Blackwell, K. Jonsdottir, M.F. Hanson, and D.M. Weir Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae Lancet 2 1986 687
80. A.L. Morrow, J. Meinzen-Derr, P. Huang, K.R. Schibler, T. Cahill, M. Keddache, and et al. Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants J. Pediatr. 158 2011 745 751 10.1016/j.jpeds.2010.10.043
81. W. Dickey, J.S. Collins, R.G. Watson, J.M. Sloan, and K.G. Porter Secretor status and Helicobacter pylori infection are independent risk factors for gastroduodenal disease Gut 34 1993 351 353 10.1136/gut.34.3.351
82. L. Maroni, S.F. van de Graaf, S.D. Hohenester, R.P. Oude Elferink, and U. Beuers Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease - a comprehensive review Clin. Rev. Allergy Immunol. 48 2015 182 191 10.1007/s12016-014-8423-1
83. D.J. Smyth, J.D. Cooper, J.M. Howson, P. Clarke, K. Downes, T. Mistry, and et al. FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection Diabetes 60 2011 3081 3084 10.2337/db11-0638
84. R.L. Currier, D.C. Payne, M.A. Staat, R. Selvarangan, S.H. Shirley, N. Halasa, and et al. Innate susceptibility to norovirus infections influenced by FUT2 genotype in a United States pediatric population Clin. Infect. Dis. 60 2015 1631 1638 10.1093/cid/civ165
85. N. Ruvoen-Clouet, G. Belliot, and J. Le Pendu Noroviruses and histo-blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution Rev. Med. Virol. 23 2013 355 366 10.1002/rmv.1757
86. G.E. Rydell, E. Kindberg, G. Larson, and L. Svensson Susceptibility to winter vomiting disease: a sweet matter Rev. Med. Virol. 21 2011 370 382 10.1002/rmv.704
87. M. Tan, and X. Jiang Histo-blood group antigens: a common niche for norovirus and rotavirus Expert Rev. Mol. Med. 16 2014 e5 10.1017/erm.2014.2
88. D.C. Payne, R.L. Currier, M.A. Staat, L.C. Sahni, R. Selvarangan, N.B. Halasa, and et al. Epidemiologic association between FUT2 secretor status and severe rotavirus gastroenteritis in children in the United States JAMA Pediatr. 1 2015 10.1001/jamapediatrics.2015.2002
89. M.W. Raza, C.C. Blackwell, P. Molyneaux, V.S. James, M.M. Ogilvie, J.M. Inglis, and et al. Association between secretor status and respiratory viral illness BMJ 303 1991 815 818
90. N.M. Chanzu, W. Mwanda, J. Oyugi, and O. Anzala Mucosal blood group antigen expression profiles and HIV infections: a study among female sex workers in Kenya PLoS ONE 10 2015 e0133049 10.1371/journal.pone.0133049
91. T. Boren, P. Falk, K.A. Roth, G. Larson, and S. Normark Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens Science 262 1993 1892 1895
92. S. Suerbaum, and P. Michetti Helicobacter pylori Infection N. Engl. J. Med. 347 2002 1175 1186 10.1056/NEJMra020542
93. A.E. Stapleton, M.R. Stroud, S.I. Hakomori, and W.E. Stamm The globoseries glycosphingolipid sialosyl galactosyl globoside is found in urinary tract tissues and is a preferred binding receptor In vitro for uropathogenic Escherichia coli expressing pap-encoded adhesins Infect. Immun. 66 1998 3856 3861
94. A. Stapleton, E. Nudelman, H. Clausen, S. Hakomori, and W.E. Stamm Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status J. Clin. Invest. 90 1992 965 972 10.1172/JCI115973
95. M. Bitzan, S. Richardson, C. Huang, B. Boyd, M. Petric, and M.A. Karmali Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro Infect. Immun. 62 1994 3337 3347
96. D.S. Newburg, S. Ashkenazi, and T.G. Cleary Human milk contains the Shiga toxin and Shiga-like toxin receptor glycolipid Gb3 J. Infect. Dis. 166 1992 832 836
97. D.S. Newburg, G.M. Ruiz-Palacios, M. Altaye, P. Chaturvedi, J. Meinzen-Derr, L. Guerrero Mde, and et al. Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants Glycobiology 14 2004 253 263 10.1093/glycob/cwh020
98. A.L. Morrow, G.M. Ruiz-Palacios, M. Altaye, X. Jiang, M.L. Guerrero, J.K. Meinzen-Derr, and et al. Human milk oligosaccharide blood group epitopes and innate immune protection against campylobacter and calicivirus diarrhea in breastfed infants Adv. Exp. Med. Biol. 554 2004 443 446 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=15384621
99. G.M. Ruiz-Palacios, L.E. Cervantes, P. Ramos, B. Chavez-Munguia, and D.S. Newburg Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection J. Biol. Chem. 278 2003 14112 14120 10.1074/jbc.M207744200
100. M.A. Higgins, E. Ficko-Blean, P.J. Meloncelli, T.L. Lowary, and A.B. Boraston The overall architecture and receptor binding of pneumococcal carbohydrate-antigen-hydrolyzing enzymes J. Mol. Biol. 411 2011 1017 1036 10.1016/j.jmb.2011.06.035
101. M. Arifuzzaman, T. Ahmed, M.A. Rahman, F. Chowdhury, R. Rashu, A.I. Khan, and et al. Individuals with Le(a + b -) blood group have increased susceptibility to symptomatic vibrio cholerae O1 infection PLoS Negl. Trop. Dis. 5 2011 e1413 10.1371/journal.pntd.0001413
102. J.B. Harris, A.I. Khan, R.C. LaRocque, D.J. Dorer, F. Chowdhury, A.S. Faruque, and et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity Infect. Immun. 73 2005 7422 7427 10.1128/iai.73.11.7422-7427.2005
103. S. Weichert, S. Jennewein, E. Hufner, C. Weiss, J. Borkowski, J. Putze, and et al. Bioengineered 2′-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines Nutr. Res. 33 2013 831 838 10.1016/j.nutres.2013.07.009
104. N. Gilboa-Garber, D. Sudakevitz, M. Sheffi, R. Sela, and C. Levene PA-I and PA-II lectin interactions with the ABO(H) and P blood group glycosphingolipid antigens may contribute to the broad spectrum adherence of Pseudomonas aeruginosa to human tissues in secondary infections Glycoconj. J. 11 1994 414 417 10.1007/BF00731276
105. S. Haataja, K. Tikkanen, J. Liukkonen, C. Francois-Gerard, and J. Finne Characterization of a novel bacterial adhesion specificity of Streptococcus suis recognizing blood group P receptor oligosaccharides J. Biol. Chem. 268 1993 4311 4317
106. J.D. Clemens, D.A. Sack, J.R. Harris, J. Chakraborty, M.R. Khan, S. Huda, and et al. ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy J. Infect. Dis. 159 1989 770 773
107. F. Qadri, M.I. Chowdhury, S.M. Faruque, M.A. Salam, T. Ahmed, Y.A. Begum, and et al. Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants Vaccine 25 2007 231 238 10.1016/j.vaccine.2006.08.031
108. C. Schneider, D.F. Smith, R.D. Cummings, K.F. Boligan, R.G. Hamilton, B.S. Bochner, and et al. The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites Sci. Transl. Med. 7 2015 269ra1 10.1126/scitranslmed.3010524
109. Y. Liu, P. Huang, B. Jiang, M. Tan, A.L. Morrow, and X. Jiang Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants PLoS ONE 8 2013 e78113 10.1371/journal.pone.0078113
110. C. Richardson, R.F. Bargatze, R. Goodwin, and P.M. Mendelman Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis Expert Rev. Vaccines 12 2013 155 167 10.1586/erv.12.145
111. R.L. Atmar, D.I. Bernstein, G.M. Lyon, J.J. Treanor, M.S. Al-Ibrahim, D.Y. Graham, and et al. Serological correlates of protection against a GII.4 norovirus Clin. Vaccine Immunol. 22 2015 923 929 10.1128/cvi.00196-15
112. P. Guillon, M. Clément, V. Sébille, J.-G. Rivain, C.-F. Chou, N. Ruvoën-Clouet, and et al. Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies Glycobiology 18 2008 1085 1093 10.1093/glycob/cwn093
113. E. Kindberg, B. Hejdeman, G. Bratt, B. Wahren, B. Lindblom, J. Hinkula, and et al. A nonsense mutation (428G-> A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection AIDS 20 2006 685 689 10.1097/01.aids.0000216368.23325.bc
114. N. Lund, M.L. Olsson, S. Ramkumar, D. Sakac, V. Yahalom, C. Levene, and et al. The human Pk histo-blood group antigen provides protection against HIV-1 infection Blood 113 2009 4980 4991 10.1182/blood-2008-03-143396
115. D.R. Branch Blood groups and susceptibility to virus infection: new developments Curr. Opin. Hematol. 17 2010 558 564 10.1097/MOH.0b013e32833ece31
116. K.E. Brown, S.M. Anderson, and N.S. Young Erythrocyte P antigen: cellular receptor for B19 parvovirus Science 262 1993 114 117
117. J. Le Pendu, S. Marionneau, A. Cailleau-Thomas, J. Rocher, B. Le Moullac-Vaidye, and M. Clement ABH and Lewis histo-blood group antigens in cancer APMIS 109 2001 9 31
118. S.R. Stowell, T. Ju, and R.D. Cummings Protein glycosylation in cancer Annu. Rev. Pathol. 10 2015 473 510 10.1146/annurev-pathol-012414-040438
119. R. Drake, and L. Ball Glycosylation and Cancer first ed. 2015 Academic Press
120. S. Hakomori, and R. Kannagi Glycosphingolipids as tumor-associated and differentiation markers J. Natl. Cancer Inst. 71 1983 231 251 10.1093/jnci/71.2.231
121. A. Kapadia, T. Feizi, D. Jewell, J. Keeling, and G. Slavin Immunocytochemical studies of blood group A, H, I, and i antigens in gastric mucosae of infants with normal gastric histology and of patients with gastric carcinoma and chronic benign peptic ulceration J. Clin. Pathol. 34 1981 320 337
122. S. Julien, G. Picco, R. Sewell, A.S. Vercoutter-Edouart, M. Tarp, D. Miles, and et al. Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model Br. J. Cancer 100 2009 1746 1754 10.1038/sj.bjc.6605083
123. L.R. Loureiro, M.A. Carrascal, A. Barbas, J.S. Ramalho, C. Novo, P. Delannoy, and et al. Challenges in antibody development against Tn and Sialyl-Tn antigens Biomolecules. 5 2015 1783 1809 10.3390/biom5031783
124. A. Magalhaes, R. Marcos-Pinto, A.V. Nairn, M.D. Rosa, R.M. Ferreira, S. Junqueira-Neto, and et al. Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways Biochim. Biophys. Acta 1852 2015 1928 1939 10.1016/j.bbadis.2015.07.001
125. R.K. Gupta, and R. Schuster Isoantigens A, B and H in benign and malignant lesions of breast Am. J. Pathol. 72 1973 253 257
126. E. Dabelsteen, P. Vedtofte, S. Hakomori, and W.W. Young Jr. Accumulation of a blood group antigen precursor in oral premalignant lesions Cancer Res. 43 1983 1451 1454
127. I. Davidsohn, S. Kovarik, and L.Y. Ni Isoantigens A, B, and H in benign and malignant lesions of the cervix Arch. Pathol. 87 1969 306 314
128. E. Dabelsteen ABO blood group antigens in oral mucosa. What is new? J. Oral Pathol. Med. 31 2002 65 70
129. T.F. Orntoft, P. Greenwell, H. Clausen, and W.M. Watkins Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis(b) blood group antigens in human colon by alpha-2-L-fucosylation Gut 32 1991 287 293
130. V. Vitiazeva, J.J. Kattla, S.A. Flowers, S.K. Linden, P. Premaratne, B. Weijdegard, and et al. The O-linked glycome and blood group antigens ABO on mucin-type glycoproteins in mucinous and serous epithelial ovarian tumors PLoS ONE 10 2015 e0130197 10.1371/journal.pone.0130197
131. P.O. Livingston, C. Hood, L.M. Krug, N. Warren, M.G. Kris, T. Brezicka, and et al. Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy Cancer Immunol. Immunother. 54 2005 1018 1025 10.1007/s00262-005-0663-8
132. S.M. Muthana, J.L. Gulley, J.W. Hodge, J. Schlom, and J.C. Gildersleeve ABO Blood Type Correlates with Survival on Prostate Cancer Vaccine Therapy, Oncotarget 2015
133. P. Wacklin, J. Tuimala, J. Nikkila, T. Sebastian, H. Makivuokko, N. Alakulppi, and et al. Faecal microbiota composition in adults is associated with the FUT2 gene determining the secretor status PLoS ONE 9 2014 e94863 10.1371/journal.pone.0094863
134. H. Makivuokko, S.J. Lahtinen, P. Wacklin, E. Tuovinen, H. Tenkanen, J. Nikkila, and et al. Association between the ABO blood group and the human intestinal microbiota composition BMC Microbiol. 12 2012 94 10.1186/1471-2180-12-94
135. M. Tong, I. McHardy, P. Ruegger, M. Goudarzi, P.C. Kashyap, T. Haritunians, and et al. Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism ISME J. 8 2014 2193 2206 10.1038/ismej.2014.64
136. J.M. Pickard, and A.V. Chervonsky Intestinal fucose as a mediator of host-microbe symbiosis J. Immunol. 194 2015 5588 5593 10.4049/jimmunol.1500395
137. P.C. Kashyap, A. Marcobal, L.K. Ursell, S.A. Smits, E.D. Sonnenburg, E.K. Costello, and et al. Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota Proc. Natl. Acad. Sci. U. S. A. 110 2013 17059 17064 10.1073/pnas.1306070110
138. R.M. Thomas, and C. Jobin The microbiome and cancer: is the "oncobiome" mirage real? Trends Cancer 1 2015 24 35 10.1016/j.trecan.2015.07.005
139. G. Pare, D.I. Chasman, M. Kellogg, R.Y. Zee, N. Rifai, S. Badola, and et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6578 women PLoS Genet. 4 2008 e1000118 10.1371/journal.pgen.1000118
140. L. Qi, M.C. Cornelis, P. Kraft, M. Jensen, R.M. van Dam, Q. Sun, and et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes Hum. Mol. Genet. 19 2010 1856 1862 10.1093/hmg/ddq057
141. L. Gallinaro, M.G. Cattini, M. Sztukowska, R. Padrini, F. Sartorello, E. Pontara, and et al. A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor Blood 111 2008 3540 3545 10.1182/blood-2007-11-122945
142. G.S. Li, H. Zhang, J.C. Lv, Y. Shen, and H.Y. Wang Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy Kidney Int. 71 2007 448 453 10.1038/sj.ki.5002088
143. S. Groux-Degroote, C. Wavelet, M.A. Krzewinski-Recchi, L. Portier, M. Mortuaire, A. Mihalache, and et al. B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract Int. J. Biochem. Cell Biol. 53 2014 442 449 10.1016/j.biocel.2014.06.009
144. FDA (US Food and Drug Administration) US Department of Health and Human Services, paving the way for personalized medicine. FDA's role in a new era of medical product development, 2015 http://www.fda.gov/down-loads/ScienceResearch/SpecialTopics/PersonalizedMedicine/UCM372421.pdf 2013
145. G. Georgi, N. Bartke, F. Wiens, and B. Stahl Functional glycans and glycoconjugates in human milk Am. J. Clin. Nutr. 98 2013 578S 585S 10.3945/ajcn.112.039065
146. D.J. Ashline, Y. Yu, Y. Lasanajak, X. Song, L. Hu, S. Ramani, and et al. Structural characterization by multistage mass spectrometry (MSn) of human milk glycans recognized by human rotaviruses Mol. Cell. Proteomics 13 2014 2961 2974 10.1074/mcp.M114.039925
147. R. Kottler, M. Mank, R. Hennig, B. Muller-Werner, B. Stahl, U. Reichl, and et al. Development of a high-throughput glycoanalysis method for the characterization of oligosaccharides in human milk utilizing multiplexed capillary gel electrophoresis with laser-induced fluorescence detection Electrophoresis 34 2013 2323 2336 10.1002/elps.201300016
148. W.M. Watkins, and W.T. Morgan Immunochemical observations on the human blood group P system J. Immunogenet. 3 1976 15 27
149. T.F. Orntoft, E.H. Holmes, P. Johnson, S. Hakomori, and H. Clausen Differential tissue expression of the Lewis blood group antigens: enzymatic, immunohistologic, and immunochemical evidence for Lewis a and b antigen expression in Le(a - b -) individuals Blood 77 1991 1389 1396
150. M.N. Christiansen, J. Chik, L. Lee, M. Anugraham, J.L. Abrahams, and N.H. Packer Cell surface protein glycosylation in cancer Proteomics 14 2014 525 546 10.1002/pmic.201300387
151. A.V. Everest-Dass, J.L. Abrahams, D. Kolarich, N.H. Packer, and M.P. Campbell Structural feature ions for distinguishing N- and O-linked glycan isomers by LC-ESI-IT MS/MS J. Am. Soc. Mass Spectrom. 24 2013 895 906 10.1007/s13361-013-0610-4
152. K.R. Reiding, D. Blank, D.M. Kuijper, A.M. Deelder, and M. Wuhrer High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification Anal. Chem. 86 2014 5784 5793 10.1021/ac500335t
153. J.A. Ferreira, M.R. Domingues, A. Reis, M.A. Monteiro, and M.A. Coimbra Differentiation of isomeric Lewis blood groups by positive ion electrospray tandem mass spectrometry Anal. Biochem. 397 2010 186 196
154. H. Zhang, S. Zhang, G. Tao, Y. Zhang, B. Mulloy, X. Zhan, and et al. Typing of blood-group antigens on neutral oligosaccharides by negative-ion electrospray ionization tandem mass spectrometry Anal. Chem. 85 2013 5940 5949 10.1021/ac400700e
155. C. Gao, Y. Zhang, Y. Liu, T. Feizi, and W. Chai Negative-ion electrospray tandem mass spectrometry and microarray analyses of developmentally-regulated antigens based on type 1 and type 2 backbone sequences Anal. Chem. 2015 10.1021/acs.analchem.5b03471
156. T. Nguyen-Khuong, A.V. Everest-Dass, L. Kautto, Z. Zhao, M.D. Willcox, and N.H. Packer Glycomic characterization of basal tears and changes with diabetes and diabetic retinopathy Glycobiology 25 2015 269 283 10.1093/glycob/cwu108
157. A.C. Vieira, H.J. An, S. Ozcan, J.H. Kim, C.B. Lebrilla, and M.J. Mannis Glycomic analysis of tear and saliva in ocular rosacea patients: the search for a biomarker Ocul. Surf. 10 2012 184 192 10.1016/j.jtos.2012.04.003
158. D. Blank, S. Gebhardt, K. Maass, G. Lochnit, V. Dotz, J. Blank, and et al. High-throughput mass finger printing and Lewis blood group assignment of human milk oligosaccharides Anal. Bioanal. Chem. 401 2011 2495 2510 10.1007/s00216-011-5349-9
159. V. Dotz, S. Rudloff, C. Meyer, G. Lochnit, and C. Kunz Metabolic fate of neutral human milk oligosaccharides in exclusively breast-fed infants Mol. Nutr. Food Res. 2014 1 10 10.1002/mnfr.201400160
160. M. Cohen, N. Hurtado-Ziola, and A. Varki ABO blood group glycans modulate sialic acid recognition on erythrocytes Blood 114 2009 3668 3676 10.1182/blood-2009-06-227041
161. G. Lauc, A. Essafi, J.E. Huffman, C. Hayward, A. Knezevic, J.J. Kattla, and et al. Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation PLoS Genet. 6 2010 e1001256 10.1371/journal.pgen.1001256